Navigation Links
Activation of microRNA inhibits cancer gene in human cancer cells

ested, was highly induced after treatment with the chromatin-remodeling drugs. Induction of miR-127 resulted in downregulation of BCL6, a known proto-oncogene. Therefore, induction of miR-127 by treatment with chromatin-remodeling drugs may have an anticancer effect.

"Taken together, our results suggest an effect of epigenetic treatment that couples inhibitors of DNA methylation and histone deacetylation to induction of some miRNAs. These miRNAs can potentially regulate expression of target genes that are important in the development and progression of human cancer. Further studies on epigenetic regulation of miRNA expression are necessary, and regulation of miRNA expression by epigenetic treatment may be a novel strategy for prevention or treatment of human cancer," offers Dr. Jones.


'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. An HIV Protein Plays a Surprising Role in Gene Activation
2. Activation of thermoreceptors mediates raw garlics burning pungency
3. Activation of a protein solidifies fear memory in the brain
4. NYU, Rockefeller researchers find complexity of regulation by microRNA genes
5. Molecular steps involved in the creation of gene-silencing microRNAs identified
6. Scientists find microRNAs regulate plant development
7. Role of microRNA identified in thyroid cancer
8. Twin molecular scissors link creation of microRNAs with gene-silencing
9. Single microRNA causes cancer in transgenic mouse
10. Pair of microRNA molecules controls major oncogene in most common leukemia
11. Unicellular microRNA discovery

Post Your Comments:
(Date:11/23/2009)...s that a common oral bacterium may exacerbate auto...al, "Unique Lipids from a Common Human Bacterium R...hancing Autoimmunity," appears in the December 200... Multiple sclerosis (MS), a disease where the imm...cts nearly 1 in 700 people in the United States. ...
(Date:11/23/2009)... the highest resolution images of peptides attachi...nderstanding how biomolecules manipulate the growt...ent for kidney stones using biomolecules. , The ...ion of the journal Proceedings of the National Ac... with mineral surfaces by accelerating, switching ...
(Date:11/23/2009)...ire microbiologist Louis Tisa has received two gra...the actinorhizal plants, widespread woody plants w...ated soils. , The United States Department of A...ecular, cellular and biomedical sciences, $399,000... bacteria Frankia and Casuarina, an actinorhizal p...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 1Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 2A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 1A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 1Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 3
... new mechanistic description of how tumor cells mi...of tumor metastasis. This new understanding holds ...is therapies. , Scientists know that tumor cells ...derstand the details of how this deadly migration ... Cancer Cell, EPFL Professor Melody Swartz and pos...
...ered how female cells are able to choose randomly ...e is always lucky. , Human males have both a X and.... This means that in an early stage in the develop... silence one of those two X chromosomes. This proc...rocess are related to serious genetic diseases. ...
... survey sponsored by CancerCare, a national nonpro...y (76 percent) of women surveyed said they know at...ain unaware of the important recent progress made ...ent) women ages 50-65 have heard of new therapies ...ss and information that women can use toward bette...
Other Biology News:Migration alert -- How tumor cells home in on the lymphatic system 2Physicist cracks women's random but always lucky choice of X chromosome 2Women well informed about breast cancer, yet lacking knowledge about current treatments 2
(Date:11/24/2009)...RNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: G...xecutiveChairman,willpresentatthe21stAnnualPiperJa...cember1,2009at10:00a.m.ET. ,, Toaccessthelivean...ttheInvestorRelationssectionofGenomicHealth,swebsi...ecttothewebsiteatleast15minutespriortothebeginning...
(Date:11/23/2009)...n a provocative new study, a University of Utah sc...s the major cause of global warming cannot be st...ociety builds the equivalent of one new nuclear po...here will be any substantial near-term departure f...de emission rates," says the new paper by Tim Garr...
(Date:11/23/2009)...swire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;...identifiesandadvancesadiverseportfolioofpromisingc...todayreportedthatCytopia(ASX:CYT)hascommencedenrol...lly-administeredJAK1/JAK2inhibitor.Thetrialisbeing...altomergeCytopiaintoYMhasbeenpreviouslyannouncedan...
(Date:11/23/2009)...PRNewswire/--Frost&Sullivan,theGrowthPartnersh...ngleadershipandinnovationThursday,November19,2009a...eldinSanAntonio,Texas. ,, (Logo: http://www.new...ealthcareInnovationAwardsaregiventocompaniesthatha...gementofhealthcare.Suchcompanieshaveshownsuccessat...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...e per capita income, retain more college graduates...options, the state announced Thursday a commitment...laureate degree programs. , ,The announcement, mad...art of the state,s strategy to play catch up in te...ees. Seven programs have been selected to receive ...
...ogy business, especially manufacturers and printer...Applied Technology Centers now under construction ... and at Waukesha County Technical College . , ,Bo...ea employers, especially in the area of workforce ...has received approval to move ahead with the Cente...
...a Madison software developer, achieved its 68th co...e months of 2006, thanks largely to a 125 percent ...d message transfer management products. , ,Citing ...ide actual sales numbers for MOVEit, but said Stan...rcent in 2005. The company employs less than 25 pe...
Other Biology Technology:State commits $500,000 to boost bachelor's degrees 2Applied Technology Centers to aid printing and manufacturing 2Applied Technology Centers to aid printing and manufacturing 3
Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.
...ing allows a high-throuput screening of a biologic...r artifitially induced changes in the expression l... studied, classified and compared to each other, c...tized scanning of the hybridized slides in Agilent...
Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human RORgamma (S-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: